In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993–2007 in Sweden
- 1 August 2010
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 16 (8) , 1104-1110
- https://doi.org/10.1111/j.1469-0691.2009.03048.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1Journal of Clinical Microbiology, 2008
- In Vitro Activities of 15 Antimicrobial Agents against 110 Toxigenic Clostridium difficile Clinical Isolates Collected from 1983 to 2004Antimicrobial Agents and Chemotherapy, 2007
- Emergence of Clostridium difficile-associated disease in North America and EuropeClinical Microbiology & Infection, 2006
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in QuebecClinical Infectious Diseases, 2005
- Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UKJournal of Hospital Infection, 2005
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month periodJournal of Medical Microbiology, 2003
- Metronidazole Resistance in Clostridium difficileClinical Infectious Diseases, 2000